Search

Search Constraints

You searched for: Author/Creator Ludvik, Bernhard

Search Results

1. Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial. Issue 4 (April 2021)

2. Changes in Cartilage and Tendon Composition of Patients With Type I Diabetes Mellitus: Identification by Quantitative Sodium Magnetic Resonance Imaging at 7 T. Issue 4 (April 2016)

3. Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real‐world studies. Issue 4 (17th December 2018)

4. Dulaglutide as add-on therapy to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes (AWARD-10): a 24-week, randomised, double-blind, placebo-controlled trial. Issue 5 (May 2018)

5. Gastric electrical stimulation treatment of type 2 diabetes: effects of implantation versus meal‐mediated stimulation. A randomized blinded cross‐over trial. Issue 7 (14th July 2015)

6. Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27, 585 people with type 1 and insulin-treated type 2 diabetes. (August 2017)

7. Influence of intravenous thiamine supplementation on blood lactate concentration prior to cardiac surgery: A double-blinded, randomised controlled pilot study. Issue 8 (August 2015)

8. Management of Pregnant Women after Bariatric Surgery. (3rd June 2018)

9. Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. Issue 10300 (14th August 2021)

10. Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial. Issue 5 (May 2019)